Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shenzhen - Delayed Quote CNY

Zhejiang Zhenyuan Share Co.,Ltd. (000705.SZ)

Compare
8.20
+0.06
+(0.74%)
At close: April 3 at 3:04:48 PM GMT+8
Loading Chart for 000705.SZ
  • Previous Close 8.14
  • Open 8.08
  • Bid 8.19 x --
  • Ask 8.20 x --
  • Day's Range 8.07 - 8.22
  • 52 Week Range 6.75 - 9.72
  • Volume 8,731,262
  • Avg. Volume 7,828,222
  • Market Cap (intraday) 2.74B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 51.25
  • EPS (TTM) 0.16
  • Earnings Date --
  • Forward Dividend & Yield 0.06 (0.73%)
  • Ex-Dividend Date Jun 7, 2024
  • 1y Target Est --

Zhejiang Zhenyuan Share Co.,Ltd. manufactures and wholesales pharmaceuticals in China and internationally. It offers Chinese herbal medicines, herbal medicine slices, and patent medicine; and pharmaceutical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provides pharmaceutical logistics, health services, etc.; produces, wholesales, and retails medicines, pre-packaged food, and dairy products, such as infant formula milk powder. The company was incorporated in 1993 and is based in Shaoxing, China.

www.zjzy.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000705.SZ

View More

Performance Overview: 000705.SZ

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000705.SZ
3.67%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

000705.SZ
2.60%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

000705.SZ
4.29%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

000705.SZ
21.51%
SSE Composite Index (000001.SS)
20.91%

Compare To: 000705.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000705.SZ

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.74B

  • Enterprise Value

    2.50B

  • Trailing P/E

    50.87

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.73

  • Price/Book (mrq)

    1.39

  • Enterprise Value/Revenue

    0.65

  • Enterprise Value/EBITDA

    29.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.44%

  • Return on Assets (ttm)

    1.15%

  • Return on Equity (ttm)

    2.88%

  • Revenue (ttm)

    3.84B

  • Net Income Avi to Common (ttm)

    55.33M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    558.61M

  • Total Debt/Equity (mrq)

    16.10%

  • Levered Free Cash Flow (ttm)

    -85.96M

Research Analysis: 000705.SZ

View More

Company Insights: 000705.SZ

Research Reports: 000705.SZ

View More

People Also Watch